Vital Farms director granted 10,436 RSUs

Ruiz Gisel reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ruiz Gisel reported acquisition or exercise transactions in this Form 4 filing.

Vital Farms director Gisel Ruiz received a new equity grant in the form of restricted stock units. The Form 4 reports an award of 10,436 shares of Common Stock at no cash cost, reflecting stock-based compensation rather than an open-market purchase.

The RSUs vest on the earlier of June 10, 2027 or the day before the company’s next annual meeting of stockholders, as long as Ruiz continues serving the company through that date. After this grant, Ruiz directly holds 56,985 shares, aligning her incentives more closely with other shareholders over the multiyear vesting period.

Insights

Equity compensation analyst

Routine director RSU grant aligns compensation with shareholders.

Vital Farms granted director Gisel Ruiz 10,436 restricted stock units, which vest on the earlier of June 10, 2027 or the day before the next annual stockholder meeting, contingent on continued service. The grant is priced at $0.00 because RSUs are compensation, not a market purchase.

Following the award, Ruiz holds 56,985 shares directly, indicating a meaningful ongoing equity stake. As a standard board compensation action with no open-market buying or selling, this filing is best viewed as routine and not thesis-changing for investors.

Insider Trade Summary

Grant/Award: 10,436 shares

Grant/Award 1 txn

Insider Ruiz Gisel

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,436	$0.00	$0.00

Holdings After Transaction: Common Stock — 56,985 shares (Direct)

Footnotes (1)

1. F1. Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of (1) June 10, 2027 and (2) the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Key Figures

RSU grant size: 10,436 shares Grant price per share: $0.00 per share Post-grant holdings: 56,985 shares +1 more

4 metrics

RSU grant size 10,436 shares Restricted stock unit award to director on June 10, 2026

Grant price per share $0.00 per share Reported transaction price for RSU award

Post-grant holdings 56,985 shares Total common shares held directly after RSU grant

Vesting date June 10, 2027 Latest vesting date, or earlier day before next annual meeting

Key Terms

restricted stock unit ("RSU") award, continuous service, annual meeting of stockholders, Grant, award, or other acquisition

4 terms

restricted stock unit ("RSU") award financial

"Represents a restricted stock unit ("RSU") award."

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer"

annual meeting of stockholders financial

"the day before the Issuer's next annual meeting of stockholders"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

What did Vital Farms (VITL) director Gisel Ruiz report in this Form 4?

Director Gisel Ruiz reported receiving a grant of 10,436 restricted stock units of Vital Farms common stock. The RSUs are a stock-based compensation award, not an open-market trade, and increase her direct holdings to 56,985 shares after the transaction.

Is the Gisel Ruiz Form 4 for Vital Farms (VITL) a stock purchase or compensation grant?

The Form 4 reflects a compensation grant, not a stock purchase. Ruiz received 10,436 restricted stock units at a reported price of $0.00 per share, consistent with equity awards granted by the company rather than shares bought in the open market.

When do Gisel Ruiz’s new Vital Farms (VITL) RSUs vest?

The 10,436 restricted stock units vest on the earlier of June 10, 2027 or the day before Vital Farms’ next annual meeting. Vesting is conditioned on Ruiz’s continuous service with the company through the applicable vesting date, typical for director equity awards.

How many Vital Farms (VITL) shares does Gisel Ruiz hold after this Form 4 transaction?

After the reported RSU grant, Gisel Ruiz directly holds 56,985 shares of Vital Farms common stock. This total includes the new 10,436-share award and reflects her equity stake following the compensation-related acquisition disclosed in the Form 4 filing.

Does the Gisel Ruiz Form 4 for Vital Farms (VITL) indicate insider buying or selling in the market?

The filing does not show market buying or selling. It reports a grant of 10,436 restricted stock units as compensation, coded as a grant or award acquisition, with no open-market purchase or sale of Vital Farms shares disclosed in this transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ruiz Gisel

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)

AUSTIN TEXAS 78704

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		10,436(1)	A	$0	56,985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of (1) June 10, 2027 and (2) the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

	/s/ Francis Cullo, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)